The Promise and Challenges of Rare Cancer Treatments

Dr. William Smith, Pioneer Institute’s Visiting Fellow in Life Sciences, spoke about the challenges and opportunities for rare cancer treatments, and concerns about cost effectiveness tools such as the Quality Adjusted Life Year (QALY), in a video interview produced by Rare Cancers, a patient group based in Australia, for the November 26th Can Forum.

Watch the video below:

Related Content:

New Report & Legal Analysis Suggests ICER’s Quality Adjusted Life Years Methodology Violates the Americans with Disabilities Act

February 10, 2020

A new report, "The Legality of QALY under the ADA," outlines several potential legal violations and negative implications for disabled individuals related to the adoption of the QALY approach to drug value assessment, used most prominently by ICER.

https://pioneerinstitute.org/wp-content/uploads/1140-man-wheelchair-disability-aarp.imgcache.rev5804edef486e77e680d3985a3ddb67dd.jpg 655 1140 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2020-02-10 07:00:262021-01-28 15:07:32New Report & Legal Analysis Suggests ICER’s Quality Adjusted Life Years Methodology Violates the Americans with Disabilities Act

Report: Rare Disease Patients Hurt by “One-Size-Fits-All” ICER Framework

0 Comments

/

June 26, 2019

This op-ed appeared in ICERWatch on June 26, 2019. The Institute…

https://pioneerinstitute.org/wp-content/uploads/icerwatch.png 400 800 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2019-06-26 00:00:252019-07-24 15:03:20Report: Rare Disease Patients Hurt by “One-Size-Fits-All” ICER Framework

New Report Addresses Distinct Challenges in Utilizing ICER to Assess Value of Rare Disease Treatments

June 24, 2019

Pioneer Institute Discourages Policymakers & Payers from…

https://pioneerinstitute.org/wp-content/uploads/questionmark-of-pills.jpg 599 900 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2019-06-24 00:01:552019-07-31 15:57:22New Report Addresses Distinct Challenges in Utilizing ICER to Assess Value of Rare Disease Treatments

Putting a Price on Life: The Coming Fight Over Government Rationing of Medical Care

0 Comments

/

June 12, 2019

This article appeared on The Mackinac Center for Public Policy…

https://pioneerinstitute.org/wp-content/uploads/doctor-crossed-arms-1.jpg 1732 1733 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2019-06-12 00:00:392021-12-29 12:18:31Putting a Price on Life: The Coming Fight Over Government Rationing of Medical Care

Here’s why Sarah Palin’s ‘death panels’ are now being debated in Massachusetts

0 Comments

/

April 25, 2019

This op-ed by Shira Schoenberg appeared in MassLive on April…

https://pioneerinstitute.org/wp-content/uploads/puppalo.jpeg 767 1145 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2019-04-25 00:00:182021-12-29 12:20:01Here’s why Sarah Palin’s ‘death panels’ are now being debated in Massachusetts

Issue Brief: Problems With The Institute of Clinical and Economic Review (ICER) and the QALY Methodology

0 Comments

/

April 23, 2019

This article by Chris Rochester appeared in The MacIver Institute…

https://pioneerinstitute.org/wp-content/uploads/maciver_icer.png 399 850 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2019-04-23 00:00:452021-01-28 15:28:07Issue Brief: Problems With The Institute of Clinical and Economic Review (ICER) and the QALY Methodology

Commentary: Proposed Drug Price Caps Would Stall Advances in Health Care

0 Comments

/

April 23, 2019

This op-ed by William Smith and Adam Crepeau appeared in the…

https://pioneerinstitute.org/wp-content/uploads/pharmacist-and-woman-1.jpg 1526 2290 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2019-04-23 00:00:112021-11-23 10:48:31Commentary: Proposed Drug Price Caps Would Stall Advances in Health Care

HHS Secretary Alex Azar doesn’t want drug access to become an equation

0 Comments

/

April 18, 2019

This op-ed by William Smith appeared in the Washington Examiner…

https://pioneerinstitute.org/wp-content/uploads/Female-doctor-talking-to-female-patient-1.jpg 1415 2122 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2019-04-18 00:00:302021-11-23 10:27:28HHS Secretary Alex Azar doesn’t want drug access to become an equation